vs
Side-by-side financial comparison of CROSS COUNTRY HEALTHCARE INC (CCRN) and IMAX CORP (IMAX). Click either name above to swap in a different company.
CROSS COUNTRY HEALTHCARE INC is the larger business by last-quarter revenue ($236.8M vs $125.2M, roughly 1.9× IMAX CORP). IMAX CORP runs the higher net margin — 0.5% vs -35.0%, a 35.5% gap on every dollar of revenue. On growth, IMAX CORP posted the faster year-over-year revenue change (35.1% vs -23.6%). IMAX CORP produced more free cash flow last quarter ($28.0M vs $16.1M). Over the past eight quarters, IMAX CORP's revenue compounded faster (25.8% CAGR vs -21.0%).
GE Healthcare Technologies, Inc. is an American health technology company based in Chicago, Illinois. The company, which stylizes its own name as GE HealthCare, operates four divisions: Medical imaging, which includes molecular imaging, computed tomography, magnetic resonance, women’s health screening and X-ray systems; Ultrasound; Patient Care Solutions, which is focused on remote patient monitoring, anesthesia and respiratory care, diagnostic cardiology, and infant care; and Pharmaceutical ...
IMAX Corporation is a Canadian production theatre company which designs and manufactures IMAX cameras and projection systems as well as performing film development, production, post-production and distribution to IMAX-affiliated theatres worldwide. Founded in Montreal in 1967, it has headquarters in the Toronto area, and operations in New York City and Los Angeles.
CCRN vs IMAX — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $236.8M | $125.2M |
| Net Profit | $-82.9M | $637.0K |
| Gross Margin | — | 57.6% |
| Operating Margin | -30.2% | 19.3% |
| Net Margin | -35.0% | 0.5% |
| Revenue YoY | -23.6% | 35.1% |
| Net Profit YoY | -2109.7% | -88.0% |
| EPS (diluted) | $-2.56 | $0.02 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $236.8M | $125.2M | ||
| Q3 25 | $250.1M | $106.7M | ||
| Q2 25 | $274.1M | $91.7M | ||
| Q1 25 | $293.4M | $86.7M | ||
| Q4 24 | $309.9M | $92.7M | ||
| Q3 24 | $315.1M | $91.5M | ||
| Q2 24 | $339.8M | $89.0M | ||
| Q1 24 | $379.2M | $79.1M |
| Q4 25 | $-82.9M | $637.0K | ||
| Q3 25 | $-4.8M | $20.7M | ||
| Q2 25 | $-6.7M | $11.3M | ||
| Q1 25 | $-490.0K | $2.3M | ||
| Q4 24 | $-3.8M | $5.3M | ||
| Q3 24 | $2.6M | $13.9M | ||
| Q2 24 | $-16.1M | $3.6M | ||
| Q1 24 | $2.7M | $3.3M |
| Q4 25 | — | 57.6% | ||
| Q3 25 | 20.4% | 63.1% | ||
| Q2 25 | 20.4% | 58.5% | ||
| Q1 25 | 20.0% | 61.4% | ||
| Q4 24 | — | 52.2% | ||
| Q3 24 | 20.4% | 55.8% | ||
| Q2 24 | 20.8% | 49.4% | ||
| Q1 24 | 20.4% | 59.3% |
| Q4 25 | -30.2% | 19.3% | ||
| Q3 25 | -2.4% | 27.2% | ||
| Q2 25 | -2.1% | 15.6% | ||
| Q1 25 | -0.3% | 19.3% | ||
| Q4 24 | -1.1% | 10.3% | ||
| Q3 24 | 0.9% | 21.2% | ||
| Q2 24 | -5.7% | 3.2% | ||
| Q1 24 | 0.8% | 15.3% |
| Q4 25 | -35.0% | 0.5% | ||
| Q3 25 | -1.9% | 19.4% | ||
| Q2 25 | -2.4% | 12.3% | ||
| Q1 25 | -0.2% | 2.7% | ||
| Q4 24 | -1.2% | 5.7% | ||
| Q3 24 | 0.8% | 15.2% | ||
| Q2 24 | -4.7% | 4.0% | ||
| Q1 24 | 0.7% | 4.1% |
| Q4 25 | $-2.56 | $0.02 | ||
| Q3 25 | $-0.15 | $0.37 | ||
| Q2 25 | $-0.20 | $0.20 | ||
| Q1 25 | $-0.02 | $0.04 | ||
| Q4 24 | $-0.13 | $0.09 | ||
| Q3 24 | $0.08 | $0.26 | ||
| Q2 24 | $-0.47 | $0.07 | ||
| Q1 24 | $0.08 | $0.06 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $108.7M | $151.2M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $322.8M | $337.9M |
| Total Assets | $449.0M | $894.0M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $108.7M | $151.2M | ||
| Q3 25 | $99.1M | $143.1M | ||
| Q2 25 | $81.2M | $109.3M | ||
| Q1 25 | $80.7M | $97.1M | ||
| Q4 24 | $81.6M | $100.6M | ||
| Q3 24 | $64.0M | $104.5M | ||
| Q2 24 | $69.6M | $91.6M | ||
| Q1 24 | $5.2M | $81.0M |
| Q4 25 | $322.8M | $337.9M | ||
| Q3 25 | $408.1M | $349.5M | ||
| Q2 25 | $412.2M | $320.4M | ||
| Q1 25 | $418.2M | $299.5M | ||
| Q4 24 | $419.0M | $299.5M | ||
| Q3 24 | $424.7M | $289.4M | ||
| Q2 24 | $433.3M | $267.2M | ||
| Q1 24 | $462.4M | $258.8M |
| Q4 25 | $449.0M | $894.0M | ||
| Q3 25 | $538.2M | $889.6M | ||
| Q2 25 | $553.8M | $868.6M | ||
| Q1 25 | $576.2M | $848.3M | ||
| Q4 24 | $589.3M | $830.4M | ||
| Q3 24 | $597.4M | $847.6M | ||
| Q2 24 | $602.9M | $827.4M | ||
| Q1 24 | $648.4M | $824.1M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $18.2M | $29.4M |
| Free Cash FlowOCF − Capex | $16.1M | $28.0M |
| FCF MarginFCF / Revenue | 6.8% | 22.3% |
| Capex IntensityCapex / Revenue | 0.9% | 1.1% |
| Cash ConversionOCF / Net Profit | — | 46.11× |
| TTM Free Cash FlowTrailing 4 quarters | $40.1M | $118.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $18.2M | $29.4M | ||
| Q3 25 | $20.1M | $67.5M | ||
| Q2 25 | $4.2M | $23.2M | ||
| Q1 25 | $5.7M | $7.0M | ||
| Q4 24 | $24.2M | $11.5M | ||
| Q3 24 | $7.5M | $35.3M | ||
| Q2 24 | $82.4M | $35.0M | ||
| Q1 24 | $6.0M | $-11.0M |
| Q4 25 | $16.1M | $28.0M | ||
| Q3 25 | $17.9M | $64.8M | ||
| Q2 25 | $2.3M | $20.9M | ||
| Q1 25 | $3.8M | $5.3M | ||
| Q4 24 | $21.7M | $6.9M | ||
| Q3 24 | $6.3M | $34.2M | ||
| Q2 24 | $79.6M | $33.5M | ||
| Q1 24 | $3.8M | $-12.1M |
| Q4 25 | 6.8% | 22.3% | ||
| Q3 25 | 7.2% | 60.7% | ||
| Q2 25 | 0.8% | 22.8% | ||
| Q1 25 | 1.3% | 6.1% | ||
| Q4 24 | 7.0% | 7.4% | ||
| Q3 24 | 2.0% | 37.3% | ||
| Q2 24 | 23.4% | 37.6% | ||
| Q1 24 | 1.0% | -15.3% |
| Q4 25 | 0.9% | 1.1% | ||
| Q3 25 | 0.9% | 2.6% | ||
| Q2 25 | 0.7% | 2.6% | ||
| Q1 25 | 0.6% | 1.9% | ||
| Q4 24 | 0.8% | 5.0% | ||
| Q3 24 | 0.4% | 1.2% | ||
| Q2 24 | 0.8% | 1.8% | ||
| Q1 24 | 0.6% | 1.4% |
| Q4 25 | — | 46.11× | ||
| Q3 25 | — | 3.27× | ||
| Q2 25 | — | 2.06× | ||
| Q1 25 | — | 2.99× | ||
| Q4 24 | — | 2.16× | ||
| Q3 24 | 2.92× | 2.54× | ||
| Q2 24 | — | 9.78× | ||
| Q1 24 | 2.23× | -3.35× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CCRN
| Temporary Staffing Services | $189.6M | 80% |
| Physician Staffing | $42.5M | 18% |
| Other Services | $4.7M | 2% |
IMAX
| Technology Sales | $46.6M | 37% |
| Image Enhancement And Maintenance Services | $38.1M | 30% |
| Joint Revenue Sharing Arrangement | $20.4M | 16% |
| Maintenance | $16.3M | 13% |
| Finance Income | $2.8M | 2% |
| Other Content Solutions | $1.6M | 1% |
